Vaccines against leptospirosis

Current Topics in Microbiology and Immunology

Volumn 387, Issue , 2015, Pages 251-272

  Adler, Ben ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIN; BACTERIUM LIPOPOLYSACCHARIDE; CHAPERONIN 60; LEMA PROTEIN; LEPTALLO I PROTEIN; LEPTOSPIROSIS VACCINE; LIGA PROTEIN; LIGB PROTEIN; LIVE VACCINE; OUTER MEMBRANE PROTEIN LIPL32; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; BACTERIAL VACCINE; LIPL32 PROTEIN, LEPTOSPIRA; LIPOPROTEIN; OUTER MEMBRANE PROTEIN;

ACTIVE IMMUNIZATION; ANTIBODY RESPONSE; ARTICLE; CROSS PROTECTION; DRUG EFFICACY; HUMAN; IMMUNOMODULATION; INFECTION PREVENTION; INFECTION RESISTANCE; LEPTOSPIROSIS; NONHUMAN; SEROTYPE; ANIMAL; IMMUNOLOGY; LEPTOSPIRA;

ANIMALIA; BOS; CANIS FAMILIARIS; CAVIA; LEPTOSPIRA; SUIDAE;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; HUMANS; LEPTOSPIRA; LEPTOSPIROSIS; LIPOPROTEINS;

EID: 84922553461     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/978-3-662-45059-8_10     Document Type: Article

References (71)

1. Alston JM, Broom JC (1958) Leptospirosis in man and animals. E & S Linvingstone, Edinburgh and London
2. Atzingen MV, Goncales AP, de Morais ZM, Araujo ER, De Brito T, Vasconcellos SA, Nascimento AL (2010) Characterization of leptospiral proteins that afford partial protection in hamsters against lethal challenge with Leptospira interrogans. J Med Microbiol 59:1005–1015
3. Atzingen MV, Vieira ML, Oliveira R, Domingos RF, Mendes RS, Barros AT, Goncales AP, de Morais ZM, Vasconcellos SA, Nascimento AL (2012) Evaluation of immunoprotective activity of six leptospiral proteins in the hamster model of leptospirosis. Open Microbiol J 6:79–87
4. Auran NE, Johnson RC, Ritzi DM (1972) Isolation of the outer sheath of Leptospira and its immunogenic properties in hamsters. Infect Immun 5:968–975
5. Branger C, Sonrier C, Chatrenet B, Klonjkowski B, Ruvoen-Clouet N, Aubert A, Andre-Fontaine G, Eloit M (2001) Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect Immun 69:6831–6838
6. Branger C, Chatrenet B, Gauvrit A, Aviat F, Aubert A, Bach JM, Andre-Fontaine G (2005) Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1. Infect Immun 73:4062–4069
7. Bulach DM, Zuerner RL, Wilson P, Seemann T, McGrath A, Cullen PA, Davis J, Johnson M, Kuczek E, Alt DP, Peterson-Burch B, Coppel RL, Rood JI, Davies JK, Adler B (2006) Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc Natl Acad Sci USA 103:14560–14565
8. Cao Y, Faisal SM, Yan W, Chang YC, McDonough SP, Zhang N, Akey BL, Chang YF (2011) Evaluation of novel fusion proteins derived from extracellular matrix binding domains of LigB as vaccine candidates against leptospirosis in a hamster model. Vaccine 29:7379–7386
9. Chang YF, Chen CS, Palaniappan RU, He H, McDonough SP, Barr SC, Yan W, Faisal SM, Pan MJ, Chang CF (2007) Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates. Vaccine 25:8190–8197
10. Christopher WL, Adler B, Faine S (1982) Immunogenicity of leptospiral vaccines grown in protein-free medium. J Med Microbiol 15:493–501
11. Coutinho ML, Choy HA, Kelley MM, Matsunaga J, Babbitt JT, Lewis MS, Aleixo JA, Haake DA (2011) A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans. PLoS Negl Trop Dis 5:e1422
12. Cullen PA, Xu X, Matsunaga J, Sanchez Y, Ko AI, Haake DA, Adler B (2005) Surfaceome of Leptospira spp. Infect Immun 73:4853–4863
13. Dai B, Chen Z, Yan H, Zhao H, Li S (1997) PCR amplification, molecular cloning, DNA sequence analysis and immunoprotection in BALB/c mice of the 33 kDa endoflagellar protein of L. interrogans serovar Lai. Chin Med Sci J 12:15–21
14. Dai B, You Z, Chen Z, Yan H, Fang Z (2000) Protection against leptospirosis by immunization with plasmid DNA encoding 33 kDa endoflagellin of L. interrogans serovar Lai. Chin Med Sci J 15:14–19
15. Deveson Lucas DS, Cullen PA, Lo M, Srikram A, Sermswan RW, Adler B (2011) Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model. Vaccine 29:3413–3418
16. Deveson Lucas DS, Lo M, Bulach DM, Quinsey NS, Murray GL, Allen A, Adler B (2014) Recombinant LipL32 stimulates gamma-interferon production in cattle vaccinated with a monovalent Leptospira borgpetersenii serovar Hardjo subtype Hardjobovis vaccine. Vet Microbiol 169:163–170
17. Faisal SM, Yan W, Chen CS, Palaniappan RU, McDonough SP, Chang YF (2008) Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Vaccine 26:277–287
18. Faisal SM, Yan W, McDonough SP, Chang CF, Pan MJ, Chang YF (2009) Leptosome-entrapped leptospiral antigens conferred significant higher levels of protection than those entrapped with PC-liposomes in a hamster model. Vaccine 27:6537–6545
19. Felix SR, Hartwig DD, Argondizzo AP, Silva EF, Seixas FK, Neto AC, Medeiros MA, Lilenbaum W, Dellagostin OA (2011) Subunit approach to evaluation of the immune protective potential of leptospiral antigens. Clin Vaccine Immunol 18:2026–2030
20. Flannery B, Costa D, Carvalho FP, Guerreiro H, Matsunaga J, Da Silva ED, Ferreira AGP, Riley LW, Reis MG, Haake DA, Ko AI (2001) Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis. J Clin Microbiol 39:3303–3310
21. Forster KM, Hartwig DD, Seixas FK, Bacelo KL, Amaral M, Hartleben CP, Dellagostin OA (2013) A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis. Clin Vaccine Immunol 20:725–731
22. Fletcher W (1928) Recent work on leptospirosis, tsutsugamushi disease, and tropical typhus in the federated Malay States. Trans R Soc Trop Med Hyg 21:265–282
23. Grassmann AA, Felix SR, dos Santos CX, Amaral MG, Seixas Neto AC, Fagundes MQ, Seixas FK, da Silva EF, Conceicao FR, Dellagostin OA (2012) Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin. Clin Vaccine Immunol 19:740–745
24. Haake DA, Mazel MK, McCoy AM, Milward F, Chao G, Matsunaga J, Wagar EA (1999) Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect Immun 67:6572–6582
25. Haake DA, Chao G, Zuerner RL, Barnett JK, Barnett D, Mazel M, Matsunaga J, Levett PN, Bolin CA (2000) The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect Immun 68:2276–2285
26. Hartwig DD, Forster KM, Oliveira TL, Amaral M, McBride AJ, Dellagostin OA (2013) A primeboost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis. Clin Vaccine Immunol 20:747–752
27. Hashimoto VL, Abreu PAE, Carvalho E, Goncales AP, Morais ZM, Vasconcellos SA, Romero EC, Ho PL (2013) Evaluation of the elastinolytic activity and protective effect of Leptallo I, a protein composed by metalloprotease and FA5/8C domains, from Leptospira interrogans Copenhageni. Microb Pathog 61–62:29–36
28. He HJ, Wang WY, Wu Z, Lv Z, Li J, Tan L (2008) Protection of guinea pigs against Leptospira interrogans serovar Lai by LipL21 DNA vaccine. Cell Mol Immunol 5:385–891
29. Ido Y, Hoki R, Ito H, Wani H (1916) The prophylaxis of Weil’s disease (Spirochaetosis icterohaemorrhagiae). J Exp Med 24:471–483
30. Jost BH, Adler B, Vinh T, Faine S (1986) A monoclonal antibody reacting with a determinant on leptospiral lipopolysaccharide protects guinea pigs against leptospirosis. J Med Microbiol 22:269–275
31. Jost BH, Adler B, Faine S (1989) Experimental immunisation of hamsters with lipopolysaccharide antigens of Leptospira interrogans. J Med Microbiol 29:115–120
32. Kemenes F (1964) Cross-immunity studies on virulent strains of leptospires belonging to different serotypes. Zetschr Immun Allergieforsch 127:209–229
33. Koizumi N, Watanabe H (2004) Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine 22:1545–1552
34. Li X, Wang Y, Yan J, Cheng D (2013) Prokaryotic expression of Leptospira interrogans groEL gene and immunoprotection of its products in hamsters. Zhejiang Da Xue Xue Bao Yi Xue Ban 42:164–710
35. Lourdault K, Wang LC, Vieira A, Matsunaga J, Melo R, Lewis MS, Haake DA, Gomes-Solecki M (2014) Oral immunization with Escherichia coli expressing a lapidated form of LigA protects hamsters against challenge with Leptospira interrogans serovar Copenhageni. Infect Immun 82:893–902
36. Luo D, Xue F, Ojcius DM, Zhao J, Mao Y, Li L, Lin X, Yan J (2010) Protein typing of major outer membrane lipoproteins from Chinese pathogenic Leptospira spp. and characterization of their immunogenicity. Vaccine 28:243–255
37. Maneewatch S, Tapchaisri P, Sakolvaree Y, Klaysing B, Tongtawe P, Chaisri U, Songserm T, Wongratanacheewin S, Srimanote P, Chongsa-nguanz M, Chaicumpa W (2007) OmpL1 DNA vaccine cross-protects against heterologous Leptospira spp. challenge. Asian Pac J Allergy Immunol 25:75–82
38. Maneewatch S, Sakolvaree Y, Saengjaruk P, Srimanote P, Tapchaisri P, Tongtawe P, Klaysing B, Wongratanacheewin S, Chongsa-Nguan M, Chaicumpa W (2008) Monoclonal antibodies to LipL32 protect against heterologous Leptospira spp. challenge. Hybridoma 27:453–465
39. Marcsisin RA, Bartpho T, Bulach DM, Srikram A, Sermswan RW, Adler B, Murray GL (2013) Use of a high-throughput screen to identify Leptospira mutants unable colonise the carrier host or cause disease in the acute model of infection. J Med Microbiol 62:1601–1608
40. Masuzawa T, Nakamura R, Shimizu T, Yanagihara Y (1990) Biological activities and endotoxic activities of protective antigens (PAgs) of Leptospira interrogans. Zentralbl Bakteriol 274:109–117
41. Matsunaga J, Barocchi MA, Croda J, Young TA, Sanchez Y, Siqueira I, Bolin CA, Reis MG, Riley LW, Haake DA, Ko AI (2003) Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol Microbiol 49:929–946
42. Matsunaga J, Sanchez Y, Xu X, Haake DA (2005) Osmolarity, a key environmental signal controlling expression of leptospiral proteins LigA and LigB and the extracellular release of LigA. Infect Immun 73:70–78
43. Matsuo K, Isogai E, Araki Y (2000) Control of immunologically crossreactive leptospiral infection by administration of lipopolysaccharides from a nonpathogenic strain of Leptospira biflexa. Microbiol Immunol 44:887–890
44. Midwinter A, Faine S, Adler B (1990) Vaccination of mice with lipopolysaccharide (LPS) and LPS-derived immuno-conjugates from Leptospira interrogans. J Med Microbiol 33:199–204
45. Midwinter A, Vinh T, Faine S, Adler B (1994) Characterization of an antigenic oligosaccharide from Leptospira interrogans serovar pomona and its role in immunity. Infect Immun 62:5477–5482
46. Murray GL, Srikram A, Hoke DE, Wunder EA Jr, Henry R, Lo M, Zhang K, Sermswan RW, Ko AI, Adler B (2009) Major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogans. Infect Immun 77:952–958
47. Murray GL (2013) The lipoprotein LipL32, an enigma of leptospiral biology. Vet Microbiol 162:305–314
48. Murray GL, Lo M, Bulach DM, Srikram A, Seemann T, Quinsey NS, Sermswan RW, Allen A, Adler B (2013) Evaluation of 238 antigens of Leptospira borgpetersenii serovar Hardjo for protection against kidney colonisation. Vaccine 31:495–499
49. Naiman BM, Alt D, Bolin CA, Zuerner R, Baldwin CL (2001) Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes. Infect Immun 69:7550–7558
50. Nascimento A, Verjovski-Almeida S, Van Sluys M, Monteiro-Vitorell C, Camargo L, Digiampietri L, Harstkeerl R, Ho P, Marques M, Oliveira M, Setubal J, Haake D, Martins E (2004) Genome features of Leptospira interrogans serovar Copenhageni. Braz J Med Biol Res 37:459–477
51. Palaniappan RU, McDonough SP, Divers TJ, Chen CS, Pan MJ, Matsumoto M, Chang YF (2006) Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun 74:1745–1750
52. Pinne M, Haake DA (2013) LipL32 Is a subsurface lipoprotein of Leptospira interrogans: presentation of new data and reevaluation of previous studies. PLoS ONE 8:e51025
53. Plesko I, Lataste-Dorolle C (1970) Intertype immunity relations of Leptospira strains belonging to the “Australis” serogroup. Biologia (Bratisl) 25:402–411
54. Plesko I, Hlavata Z (1971) Cross immunity studies with lipase negative strains of leptospires. Biol (Brat) 26:689–693
55. Que-Gewirth NLS, Ribeiro AA, Kalb SR, Cotter RJ, Bulach DM, Adler B, Saint Girons I, Werts C, Raetz CRH (2004) A methylated phosphate group and four amide-linked acyl chains in Leptospira interrogans Lipid A: the membrane anchor of an unusual lipopolysaccharide that activates TLR2. J Biol Chem 279:25420–25429
56. Ricaldi J, Matthias M, Vinetz J, Lewis A (2012) Expression of sialic acids and other nonulosonic acids in Leptospira. BMC Microbiol 12:161
57. Rosario LA, Arencibia DF, Suarez YE, Infante JF, Valdes BY, Batista N (2012) Cross-protection among unrelated Leptospira pathogens serovars: an unfinished story. Adv Clin Exp Med 21:581–589
58. Rottini GD, Cinco M, Panizon F, Agosti E (1972) Comportamento dell Ig seriche nell’uomo dopo vaccinazione con leptospira saprofita (ceppo Patoc 1). G Mal Infett Parassit 24:879–885
59. Schoone GJ, Everard COR, Korver H, Carrington DG, Inniss VA, Baulu J, Terpstra WJ (1989) An immunoprotective monoclonal antibody directed against Leptospira interrogans serovar copenhageni. J Gen Microbiol 135:73–78
60. Seixas FK, da Silva EF, Hartwig DD, Cerqueira GM, Amaral M, Fagundes MQ, Dossa RG, Dellagostin OA (2007) Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 26:88–95
61. Shinagawa M, Yanagawa R (1972) Isolation and characterization of a leptospiral type-specific antigen. Infect Immun 5:12–19
62. Sonrier C, Branger C, Michel V, Ruvoen-Clouet N, Ganiere JP, Andre-Fontaine G (2000) Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine 19:86–94
63. Silva EF, Medeiros MA, McBride AJ, Matsunaga J, Esteves GS, Ramos JG, Santos CS, Croda J, Homma A, Dellagostin OA, Haake DA, Reis MG, Ko AI (2007) The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 25:6277–6286
64. Srikram A, Zhang K, Bartpho T, Lo M, Hoke DE, Sermswan RW, Adler B, Murray GL (2010) Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant. J Infect Dis 203:870–879
65. Stalheim OH (1968) Vaccination of hamsters, swine, and cattle with viable, avirulent Leptospira pomona. Am J Vet Res 29:1463–1468
66. Stalheim OH (1971) Duration of immunity in cattle in response to a viable, avirulent Leptospira pomonavaccine. Am J Vet Res 32:851–854
67. Torten M, Shenberg E, Gerichter CB, Neuman P, Klingberg MA (1973) A new leptospiral vaccine for use in man. II. Clinical and serologic evaluation of a field trial with volunteers. J Infect Dis 128:647–651
68. Vinh T, Shi M-H, Adler B, Faine S (1989) Characterization and taxonomic significance of lipopolysaccharides of Leptospira interrogans serovar hardjo. J Gen Microbiol 135:2663–2673
69. Yan W, Faisal SM, McDonough SP, Divers TJ, Barr SC, Chang CF, Pan MJ, Chang YF (2009) Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model. Microbes Infect 11:230–237
70. Yan W, Faisal SM, McDonough SP, Chang CF, Pan MJ, Akey B, Chang YF (2010) Identification and characterization of OmpA-like proteins as novel vaccine candidates for leptospirosis. Vaccine 28:2277–2283
71. Zhang K, Murray GL, Seemann T, Srikram A, Bartpho T, Sermswan RW, Adler B, Hoke DE (2013) Leptospiral LruA is required for virulence and modulates an interaction with mammalian Apolipoprotein A-I. Infect Immun 81:3872–3879